Patents by Inventor Philippe Boffelli

Philippe Boffelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8461312
    Abstract: The invention relates to a method for producing 1,4-benzothiepin-1,1-dioxide derivatives substituted with benzyl groups.
    Type: Grant
    Filed: April 29, 2009
    Date of Patent: June 11, 2013
    Assignee: Sanofi
    Inventors: Guenter Billen, Wendelin Frick, John Patrick Larkin, Guy Lemaitre, Francoise Bendetti, Philippe Boffelli, Jean-Yves Godard, Christian Masson, Veronique Crocq, Sylvaine Lafont, Jos Hulshof
  • Patent number: 8207355
    Abstract: This invention discloses and claims an industrial method for the production of azetidine derivatives, such as, N-(1-benzhydrylazetidin-3-yl)-N-phenylmethylsulphonamide.
    Type: Grant
    Filed: June 14, 2010
    Date of Patent: June 26, 2012
    Assignee: Sanofi-Aventis
    Inventors: Antony Bigot, Philippe Boffelli, Maxime Lampilas, Pascale Marolleau, Alain Medard, Gilles Oddon, Daniel Varraillon
  • Patent number: 8071788
    Abstract: The invention relates to a novel method for the synthesis of N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-(3,5 -difluorophenyl)methylsulfonamide.
    Type: Grant
    Filed: December 11, 2009
    Date of Patent: December 6, 2011
    Assignee: Sanofi-Aventis
    Inventors: Philippe Boffelli, Michel Delthil, Luc Grondard, Maxime Lampilas, Joel Malpart, Stephane Mutti, Lahlou Nait-Bouda, Joerg Reike-Zapp
  • Publication number: 20110245486
    Abstract: The invention relates to a method for producing 1,4-benzothiepin-1,1-dioxide derivatives substituted with benzyl groups.
    Type: Application
    Filed: April 29, 2009
    Publication date: October 6, 2011
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Guenter Billen, Wendelin Frick, John Patrick Larkin, Guy Lemaitre, Francoise Bendetti, Philippe Boffelli, Jean-Yves Godard, Christian Masson, Veronique Crocq, Sylvaine Lafont, Jos Hulshof
  • Publication number: 20110118481
    Abstract: This invention discloses and claims an industrial method for the production of azetidine derivatives, such as, N-(1-benzhydrylazetidin-3-yl)-N-phenylmethylsulphonamide.
    Type: Application
    Filed: June 14, 2010
    Publication date: May 19, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Antony Bigot, Philippe Boffelli, Maxime Lampilas, Pascale Marolleau, Alain Medard, Gilles Oddon, Daniel Varraillon
  • Publication number: 20100273977
    Abstract: A subject of the invention is a process for the preparation of the compounds of formula (I): R being as defined in the description as well as their salts, the intermediates, the use of the dihydrochloride as a medicament and the pharmaceutical compositions containing them. The process for preparing formula (I) leads to greater than 50% yield of isomer A, and its intended use, e.g. as an antifungal medicament.
    Type: Application
    Filed: July 6, 2010
    Publication date: October 28, 2010
    Inventors: Philippe Boffelli, Agnes Brouillard, Colette Colladant, Serge Droux, Michel Elter, Didier Ferroud, Guy Lemaitre, Joseph Paladino
  • Publication number: 20100087414
    Abstract: The invention relates to a novel method for the synthesis of N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-(3,5 -difluorophenyl)methylsulfonamide.
    Type: Application
    Filed: December 11, 2009
    Publication date: April 8, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Philippe BOFFELLI, Michel DELTHIL, Luc GRONDARD, Maxime LAMPILAS, Joel MALPART, Stephane MUTTI, Lahlou NAIT-BOUDA, Joerg RIEKE-ZAPP
  • Patent number: 7652154
    Abstract: The invention relates to a novel method for the synthesis of N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-(3,5-difluorophenyl)methylsulfonamide.
    Type: Grant
    Filed: August 20, 2008
    Date of Patent: January 26, 2010
    Assignee: Sanofi-Aventis
    Inventors: Philippe Boffelli, Michel Delthil, Luc Grondard, Maxime Lampilas, Joel Malpart, Stephane Mutti, Lahlou Nait-Bouda, Joerg Reike-Zapp
  • Publication number: 20080312205
    Abstract: The invention relates to a novel method for the synthesis of N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-(3,5-difluorophenyl)methylsulfonamide.
    Type: Application
    Filed: August 20, 2008
    Publication date: December 18, 2008
    Applicant: SANOFI-AVENTIS
    Inventors: Philippe BOFFELLI, Michel DELTHIL, Luc GRONDARD, Maxime LAMPILAS, Joel MALPART, Stephane MUTTI, Lahlou NAIT-BOUDA, Joerg RIEKE-ZAPP
  • Patent number: 7429668
    Abstract: The invention relates to a novel method for the synthesis of N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-(3,5-difluorophenyl)methylsulfonamide.
    Type: Grant
    Filed: March 28, 2007
    Date of Patent: September 30, 2008
    Assignee: Sanofi-Aventis
    Inventors: Philippe Boffelli, Michel Delthil, Luc Grondard, Maxime Lampilas, Joel Malpart, Stephane Mutti, Lahlou Nait-Bouda, Joerg Rieke-Zapp
  • Publication number: 20070244084
    Abstract: The invention relates to a novel method for the synthesis of N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-(3,5-difluorophenyl)methylsulfonamide.
    Type: Application
    Filed: March 28, 2007
    Publication date: October 18, 2007
    Applicant: AVENTIS PHARMA SA
    Inventors: Philippe Boffelli, Michel Delthil, Luc Grondard, Maxime Lampilas, Joel Malpart, Stephane Mutti, Lahlou Nait-Bouda, Joerg Rieke-Zapp
  • Publication number: 20070105760
    Abstract: A subject of the invention is a process for the preparation of the compounds of formula (I): R being as defined in the description as well as their salts, the intermediates, the use of the dihydrochloride as a medicament and the pharmaceutical compositions containing them. The process for preparing formula (I) leads to greater than 50% yield of isomer A, and its intended use, e.g. as an antifungal medicament.
    Type: Application
    Filed: November 2, 2006
    Publication date: May 10, 2007
    Inventors: Philippe Boffelli, Agnes Brouillard, Colette Colladant, Serge Droux, Michel Elter, Didier Ferroud, Guy Lemaitre, Joseph Paladino
  • Patent number: 7148322
    Abstract: A subject of the invention is a process for the preparation of the compounds of formula (I): R being as defined in the description as well as their salts, the intermediates, the use of the dihydrochloride as a medicament and the pharmaceutical compositions containing them. The process for preparing formula (I) leads to greater than 50% yields of isomer A, and its intended use, e.g. as an antifungal medicament.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: December 12, 2006
    Inventors: Philippe Boffelli, Agnes Brouillard, Colette Colladant, Serge Droux, Michel Elter, Didier Ferroud, Guy Lemaitre, Joseph Paladino
  • Publication number: 20050032679
    Abstract: A subject of the invention is a process for the preparation of the compounds of formula (I): R being as defined in the description as well as their salts, the intermediates, the use of the dihydrochloride as a medicament and the pharmaceutical compositions containing them.
    Type: Application
    Filed: June 14, 2004
    Publication date: February 10, 2005
    Applicant: Aventis Pharma S.A.
    Inventors: Philippe Boffelli, Agnes Brouillard, Colette Colladant, Serge Droux, Michel Elter, Didier Ferroud, Guy Lemaitre, Joseph Paladino